Cargando…
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis
BACKGROUND: The burden of cancer in heart failure with reduced ejection fraction is apparently growing. Randomized controlled trials (RCTs) may help understanding this observation, since they span decades of heart failure treatment. METHODS AND RESULTS: We assessed cancer, cardiovascular, and total...
Autores principales: | Tini, Giacomo, Bertero, Edoardo, Signori, Alessio, Sormani, Maria Pia, Maack, Christoph, De Boer, Rudolf A., Canepa, Marco, Ameri, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726990/ https://www.ncbi.nlm.nih.gov/pubmed/32862764 http://dx.doi.org/10.1161/JAHA.119.016309 |
Ejemplares similares
-
Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
por: Bertero, Edoardo, et al.
Publicado: (2019) -
Special prognostic phenomenon for patients with mid-range ejection fraction heart failure: a systematic review and meta-analysis
por: Guo, Pan, et al.
Publicado: (2020) -
Real-World Safety of Sacubitril/Valsartan in Women and Men With Heart Failure and Reduced Ejection Fraction: A Meta-analysis
por: Nuechterlein, Kaitlin, et al.
Publicado: (2021) -
Global status and trends in heart failure with preserved ejection fraction over the period 2009-2020: A bibliometric analysis
por: Dong, Qiuju, et al.
Publicado: (2022) -
Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis
por: Morris, Daniel Armando, et al.
Publicado: (2017)